Correlation Between Apogee Therapeutics, and Univest Pennsylvania

Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and Univest Pennsylvania at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and Univest Pennsylvania into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Apogee Therapeutics, Common and Univest Pennsylvania, you can compare the effects of market volatilities on Apogee Therapeutics, and Univest Pennsylvania and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of Univest Pennsylvania. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and Univest Pennsylvania.

Diversification Opportunities for Apogee Therapeutics, and Univest Pennsylvania

-0.61

Correlation Coefficient

Apogee Therapeutics,  Univest Pennsylvania

Excellent diversification

The 3 months correlation between Apogee and Univest is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and Univest Pennsylvania in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Univest Pennsylvania and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with Univest Pennsylvania. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Univest Pennsylvania has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and Univest Pennsylvania go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and Univest Pennsylvania

Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to under-perform the Univest Pennsylvania. In addition to that, Apogee Therapeutics, is 1.63 times more volatile than Univest Pennsylvania. It trades about -0.06 of its total potential returns per unit of risk. Univest Pennsylvania is currently generating about 0.08 per unit of volatility. If you would invest  2,688  in Univest Pennsylvania on September 25, 2024 and sell it today you would earn a total of  278.00  from holding Univest Pennsylvania or generate 10.34% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Apogee Therapeutics, Common  vs.  Univest Pennsylvania

Apogee Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Univest Pennsylvania

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Univest Pennsylvania are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile basic indicators, Univest Pennsylvania may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Apogee Therapeutics, and Univest Pennsylvania

The main advantage of trading using opposite Apogee Therapeutics, and Univest Pennsylvania positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, Univest Pennsylvania can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Univest Pennsylvania will offset losses from the drop in Univest Pennsylvania's long position.

The idea behind Apogee Therapeutics, Common and Univest Pennsylvania pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.